# 2025-22496: DEA Extends Ban on Drug With Unpronounceable Sci-Fi Name

2025-22496, Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2025-12-11, effective 2025-12-12 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-22496
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-22496
- Title: Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 57542
- Published: 2025-12-11
- Effective: 2025-12-12
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

DEA Extends Ban on Drug With Unpronounceable Sci-Fi Name

## Summary

The DEA is extending the temporary ban on CUMYL-PEGACLONE, keeping it in the strictest drug category (Schedule I) for another year starting December 12, 2025. This means anyone making, selling, or using this substance faces serious legal rules and penalties until a permanent decision is made. The extension helps keep communities safe while the government finishes its review.

## Abstract

The Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of CUMYL-PEGACLONE. In an order dated December 12, 2023, DEA temporarily placed CUMYL-PEGACLONE in schedule I of the Controlled Substances Act. This temporary order will extend the temporary scheduling of CUMYL-PEGACLONE for one year, or until the permanent scheduling action for this substance is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle CUMYL-PEGACLONE.

## Effects PRIA read

- CUMYL-PEGACLONE Kept in Schedule I: cost, high. The DEA extended the temporary Schedule I placement of CUMYL-PEGACLONE (including its salts and isomers) effective December 12, 2025, through December 12, 2026, or until permanent scheduling occurs. While it is in Schedule I, the regulatory controls and the administrative, civil, and criminal sanct…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-22496 on federalregister.gov](https://www.federalregister.gov/documents/2025/12/11/2025-22496/schedules-of-controlled-substances-extension-of-temporary-placement-of-cumyl-pegaclone-in-schedule-i)
- [2025-22496 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-12-11/pdf/2025-22496.pdf)

## Related
- [Previous: 2025-22449, Transfer of the Functions of the Tax Division to the Civil Division and the Cri…](https://policyrisk.com/federal-register/2025-22449)
- [Next: 2025-22501, Modification and Revocation of Class E Airspace; Hawaiian Islands, HI; Correcti…](https://policyrisk.com/federal-register/2025-22501)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-22496 (as of 2026-06-11).
